Modulation of actin isoform expression before the transition from experimental compensated pressure-overload cardiac hypertrophy to decompensation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 296, Issue 5, 2009, Pages

  Berni, Roberta ^a   Savi, Monia ^a   Bocchi, Leonardo ^a   Delucchi, Francesca ^a   Musso, Ezio ^a   Chaponnier, Christine ^b   Gabbiani, Giulio ^b   Clement, Sophie ^b   Stilli, Donatella ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Aortic ligature; Hypertension

Indexed keywords

ALPHA ACTIN; ALPHA CARDIAC ACTIN; ALPHA SKELETAL ACTIN; ALPHA SMOOTH MUSCLE ACTIN; CALCIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HYPERTENSION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MORPHOMETRICS; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ACTINS; ADAPTATION, PHYSIOLOGICAL; ANIMALS; ARTERIOLES; CALCIUM SIGNALING; CARDIOMEGALY; CORONARY VESSELS; DISEASE MODELS, ANIMAL; FIBROSIS; HEART FAILURE; HEMODYNAMICS; HYPERTENSION; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PROTEIN ISOFORMS; RATS; RATS, WISTAR; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 66149137505     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01057.2008     Document Type: Article

References (43)

1. Anamourlis C, Badenhorst D, Gibbs M, Correia R, Veliotes D, Osadchii O, Norton GR, Woodiwiss AJ. Phosphodiesterase inhibition promotes the transition from compensated hypertrophy to cardiac dilatation in rats. Pflügers Arch 451: 526-533, 2006. (Pubitemid 41789793)
2. Arai M, Suzuki T, Nagai R. Sarcoplasmic reticulum genes are upregulated in mild cardiac hypertrophy but downregulated in severe cardiac hypertrophy induced by pressure overload. J Mol Cell Cardiol 28: 1583-1590, 1996. (Pubitemid 26300560)
3. Badenhorst D, Veliotes D, Maseko M, Tsotetsi OJ, Brooksbank R, Naidoo A, Woodiwiss AJ, Norton GR. α-Adrenergic activation initiates chamber dilatation in concentric hypertrophy. Hypertension 41: 499-504, 2003. (Pubitemid 36314623)
4. Carvalho BMR,. Bassani RA, Franchini KG, Bassani JWM. Enhanced calcium mobilization in rat ventricular myocytes during the onset of pressure overload-induced hypertrophy. Am J Physiol Heart Circ Physiol 291: H1803-H1813, 2006.
5. Cheng H, Huang XN, Stewart AF, Sepulveda JL. Gene expression changes associated with fibronectin-induced cardiac myocyte hypertrophy. Physiol Genomics 18: 273-283, 2004.
6. Chen-Izu Y, Chen L, Banyasz T, McCulle SL, Norton B, Scharf SM, Agarwal A, Patwardhan A, Izu LT, Balke CW. Hypertension-induced remodeling of cardiac excitation-contraction coupling in ventricular myocytes occurs prior to hypertrophy development. Am J Physiol Heart Circ Physiol 293: H3301-H3310, 2007. (Pubitemid 350230870)
7. Clement S, Chaponnier C, Gabbiani G. A subpopulation of cardiomyocytes expressing alpha-skeletal actin is identified by a specific polyclonal antibody. Circ Res 85: 51-58, 1999.
8. Clement S, Orlandi A, Bocchi L, Pizzolato G, Foschini MP, Eusebi V, Gabbiani G. Actin isoform pattern expression: a tool for the diagnosis and biological characterization of human rhabdomyosarcoma. Virchows Arch 442: 31-38, 2003. (Pubitemid 36216356)
9. Dodge HT, Baxley WA. Left ventricular volume and mass and their significance in heart disease. Am J Cardiol 23: 528-537, 1969.
10. Fortuno MA, Ravassa S, Fortuno A, Zalba G, Diez J. Cardiomyocyte apoptotic cell death in arterial hypertension: mechanisms and potential management. Hypertension 38: 1406-1412, 2001. (Pubitemid 34033424)
11. Gradman AH, Alfayoumi F. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. Prog Cardiovasc Dis 48: 326-341, 2006.
12. Graham HK, Trafford AW. Spatial disruption and enhanced degradation of collagen with the transition from compensated ventricular hypertrophy to symptomatic congestive heart failure. Am J Physiol Heart Circ Physiol 292: H1364-H1372, 2007.
13. Hein S, Kostin S, Heling A, Maeno Y, Schaperb J. The role of the cytoskeleton in heart failure. Cardiovasc Res 45: 273-278, 2000. (Pubitemid 30069492)
14. Hewett TE, Grupp IL, Grupp G, Robbins J. Alpha-skeletal actin is associated with increased contractility in the mouse heart. Circ Res 74: 740-746, 1994. (Pubitemid 24088534)
15. Higashiyama H, Sugai M, Inoue H, Mizuyachi K, Kushida H, Asano S, Kinoshita M. Histopathological study of time course changes in inter-renal aortic banding-induced left ventricular hypertrophy of mice. Int J Exp Pathol 88: 31-38, 2007. (Pubitemid 46145605)
16. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol 170: 1807-1816, 2007. (Pubitemid 47339255)
17. 2+ ATPase modifies the transition from hypertrophy to early heart failure. Circ Res 89: 422-429, 2001.
18. Kuhn M, Holtwick R, Baba HA, Perriard JC, Schmitz W, Ehler E. Progressive cardiac hypertrophy and dysfunction in atrial natriuretic peptide receptor (GC-A) deficient mice. Heart 87: 368-374, 2002. (Pubitemid 34270952)
19. Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K, Imaizumi T. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 106: 130-135, 2002. (Pubitemid 34747453)
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
21. Lewinter MM, Vanburen P. Myofilament remodeling during the progression of heart failure. J Card Fail 8: S271-S275, 2002.
22. Lindsey ML, Goshorn DK, Comte-Walters S, Hendrick JW, Hapke E, Zile MR, Schey K. A multidimensional proteomic approach to identify hypertrophy- associated proteins. Proteomics 6: 2225-2235, 2006.
23. Moorjani N, Ahmad M, Catarino P, Brittin R, Trabzuni D, Al-Mohanna F, Narula N, Narula J, Westaby S. Activation of apoptotic caspase cascade during the transition to pressure overload-induced heart failure. J Am Coll Cardiol 48: 1451-1458, 2006. (Pubitemid 44436811)
24. Myreng Y, Smiseth OA. Assessment of left ventricular relaxation by Doppler echocardiography. Comparison of isovolumic relaxation time and transmitral flow velocities with time constant isovolumic relaxation. Circulation 81: 260-266, 1990. (Pubitemid 20031790)
25. Natali AJ, Wilson LA, Peckham M, Turner DL, Harrison SM, White E. Different regional effects of voluntary exercise on the mechanical and electrical properties of rat ventricular myocytes. J Physiol 541: 863-875, 2002. (Pubitemid 35190246)
26. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodelling. Lancet 367: 356-367, 2006.
27. Pillai JB, Russell HM, Raman J, Jeevanandam V, Gupta MP. Increased expression of poly(ADP-ribose) polymerase-1 contributes to caspase-independent myocyte cell death during heart failure. Am J Physiol Heart Circ Physiol 288: H486-H496, 2005. (Pubitemid 40139629)
28. Rafalski K, Abdourahman A, Edwards JG. Early adaptations to training: upregulation of alpha-myosin heavy chain gene expression. Med Sci Sports Exerc 39: 75-82, 2007. (Pubitemid 46095802)
29. Rota M, Hosoda T, De Angelis A, Arcarese ML, Esposito G, Rizzi R, Tillmanns J, Tugal D, Musso E, Rimoldi O, Bearzi C, Urbanek K, Anversa P, Leri A, Kajstura J. The young mouse heart is composed of myocytes heterogeneous in age and function. Circ Res 101: 387-399, 2007. (Pubitemid 47267707)
30. Rysa J, Leskinen H, Ilves M, Ruskoaho H. Distinct upregulation of extracellular matrix genes in transition from hypertrophy to hypertensive heart failure. Hypertension 45: 927-933, 2005. (Pubitemid 40628939)
31. Schroen B, Leenders JJ, van Erk A, Bertrand AT, van Loon M, van Leeuwen RE, Kubben N, Duisters RF, Schellings MW, Janssen BJ, Debets JJ, Schwake M, Hoydal MA, Heymans S, Saftig P, Pinto YM. Lysosomal integral membrane protein 2 is a novel component of the cardiac intercalated disc and vital for load-induced cardiac myocyte hypertrophy. J Exp Med 204: 1227-1235, 2007. (Pubitemid 46798164)
32. Schurch W, Skalli O, Seemayer TA, Gabbiani G. Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. I. Smooth muscle tumors. Am J Pathol 128: 91-103, 1987. (Pubitemid 17094339)
33. Schwartz K, de la Bastie D, Bouveret P, Oliviero P, Alonso & Buckingham M S. α-Skeletal muscle actin mRNA's accumulate in hypertrophied adult rat hearts. Circ Res 59: 551-555, 1986. (Pubitemid 17000931)
34. Shirwany A, Weber KT. Extracellular matrix remodeling in hypertensive heart disease. J Am Coll Cardiol 48: 97-98, 2006.
35. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 103: 2787-2796, 1986. (Pubitemid 17008024)
36. Stilli D, Bocchi L, Berni R, Zaniboni M, Cacciani F, Chaponnier C, Musso E, Gabbiani G, Clement S. Correlation of alpha-skeletal actin expression, ventricular fibrosis and heart function with the degree of pressure overload cardiac hypertrophy in rats. Exp Physiol 91: 571-580, 2006.
37. Suurmeijer AJ, Clement S, Francesconi A, Bocchi L, Angelini A, Van Veldhuisen DJ, Spagnoli LG, Gabbiani G, Orlandi A. Alpha-actin isoform distribution in normal and failing human heart: a morphological, morphometric, and biochemical study. J Pathol 199: 387-397, 2003. (Pubitemid 36266862)
38. Towbin H, Staehelin T, Gordon J. Electophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979. (Pubitemid 9256559)
39. VanBuren P, Okada Y. Thin filament remodeling in failing myocardium. Heart Fail Rev 10: 199-209, 2005. (Pubitemid 43118300)
40. Weber KT. Fibrosis and hypertensive heart disease. Curr Opin Cardiol 15: 264-272, 2000.
41. Willems IE, Havenith MG, De Mey JG, Daemen MJ. The alpha-smooth muscle actin-positive cells in healing human myocardial scars. Am J Pathol 145: 868-875, 1994.
42. Yamamoto K, Mano T, Yoshida J, Sakata Y, Nishikawa N, Nishio M, Ohtani T, Hori M, Miwa bT, Masuyama T. ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure. J Hypertens 23: 393-400, 2005. (Pubitemid 40279643)
43. Zaniboni M, Pollard AE, Yang L, Spitzer KW. Beat-to-beat repolarization variability in ventricular myocytes and its suppression by electrical coupling. Am J Physiol Heart Circ Physiol 278: H677-H687, 2000. (Pubitemid 30152522)